Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Senseonics Holdings (SENS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 479,264
  • Shares Outstanding, K 176,850
  • Annual Sales, $ 6,370 K
  • Annual Income, $ -59,100 K
  • 36-Month Beta 1.55
  • Price/Sales 32.74
  • Price/Cash Flow N/A
  • Price/Book 6.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate -0.13
  • Low Estimate -0.19
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.42 +11.98%
on 12/24/18
2.98 -9.06%
on 01/08/19
+0.11 (+4.23%)
since 12/21/18
3-Month
2.26 +19.91%
on 12/21/18
4.15 -34.70%
on 10/24/18
-0.75 (-21.68%)
since 10/22/18
52-Week
2.26 +19.91%
on 12/21/18
5.29 -48.77%
on 06/22/18
-0.25 (-8.45%)
since 01/22/18

Most Recent Stories

More News
Detailed Research: Economic Perspectives on Inovalon, Merit Medical, Senseonics, Ocular Therapeutix, The Hartford Financial Services Group, and Synopsys -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Inovalon Holdings, Inc....

SENS : 2.71 (-0.73%)
MMSI : 53.67 (+0.13%)
HIG : 46.21 (-1.01%)
SNPS : 89.79 (-1.86%)
INOV : 14.39 (-0.48%)
OCUL : 3.75 (-4.82%)
Senseonics Appoints Jon D. Isaacson as Chief Financial Officer

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.71 (-0.73%)
Senseonics Holdings Commercial Development of Eversense, Analysts Review and Target

NEW YORK, NY / ACCESSWIRE / January 7, 2019 / Traders News Source, aleading independent equity research and corporate access firm focused on smalland mid-cap public companies is issuing a comprehensive...

SENS : 2.71 (-0.73%)
Implied Volatility Surging for Senseonics Holdings (SENS) Stock Options

Senseonics Holdings (SENS) needs investors to pay close attention to the stock based on moves in the options market lately.

SENS : 2.71 (-0.73%)
Senseonics Holdings, Inc. Announces Retirement of Chief Financial Officer

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.71 (-0.73%)
Eversense CGM Wins a 2018 "Best of What's New" Award

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.71 (-0.73%)
Report: Exploring Fundamental Drivers Behind Sterling Construction, Tredegar, j2 Global, Medical Transcription Billing, Concert Pharmaceuticals, and Senseonics -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Sterling Construction Company...

SENS : 2.71 (-0.73%)
CNCE : 14.28 (+0.42%)
TG : 16.56 (-2.36%)
JCOM : 72.74 (-1.46%)
STRL : 13.21 (-0.68%)
MTBC : 4.30 (-5.49%)
Senseonics Holdings (SENS) Reports Q3 Loss, Tops Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 6.67% and 6.57%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

SENS : 2.71 (-0.73%)
Senseonics Holdings, Inc. Reports Third Quarter 2018 Financial Results

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.71 (-0.73%)
Earnings Preview: Senseonics Holdings (SENS) Q3 Earnings Expected to Decline

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SENS : 2.71 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade SENS with:

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

2nd Resistance Point 2.82
1st Resistance Point 2.76
Last Price 2.71
1st Support Level 2.63
2nd Support Level 2.56

See More

52-Week High 5.29
Fibonacci 61.8% 4.13
Fibonacci 50% 3.78
Fibonacci 38.2% 3.42
Last Price 2.71
52-Week Low 2.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar